NanoViricides, a Shelton-based company, says its anti-COVID medication candidate would come in a variety of forms, from gummies to inhalants.
The company says it is completing an Investigators Medicinal Product Dossier, which is required for its clinical trial application for its lead drug candidate against COVID-19, called NV-CoV-2.